Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

NCT Number	NCT07447635
Lead Sponsor	H. Lee Moffitt Cancer Center and Research Institute Collaborators: Florida Biomedical Research Program - James & Esther King
Conditions	Smoking Cessation, Alcohol Use
Enrollment	600 participants
Start Date	2026-05-15
Primary Completion	2029-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-18